Organoids Market to Expand with Significant CAGR During 2019-2029

1
Organoids Market to Partake Significant
Development During 2019-2029

• March 2020

Report Id REP-GB-8106 Published On
September-2019 Category Healthcare,
Pharmaceuticals Medical Devices
2
AboutFuture Market Insights
Future Market Insights (FMI) is a premier
provider of syndicated research reports, custom
research reports, and consulting services. We
deliver a complete packaged solution, which
combines current market intelligence, statistical
anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive
framework, and future market trends. We provide
research services at a global as well as regional
level key regions include GCC, ASEAN,
and BRIC. Our offerings cover a broad spectrum of
industries including Chemicals, Materials,
Energy, Technology, Healthcare, and Retail. We
have a global presence with delivery centers
across India specializing in providing global
research reports and country research reports.
FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Research Capabilities
Sector Coverage

• Customized Research
• Syndicated Research
• Investment Research
• Social Media Research

• Automotive and Transportation
• Electronics, Semiconductor, and ICT
• Retail and Consumer Products
• Industrial Automation and Equipment

• Chemicals Materials
• Food and Beverages
• Services and Utilities
• Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please
contact Hari. T (Sr. Manager - Global Business
Development) T 44 (0) 20 7692 8790 D 44
20 3287 4268 Email hari.t_at_futuremarketinsights.co
m
3
Research Methodology (1/2)

• Systematic Research Approach

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc.
FMI formulates a detailed discussion guide to conduct expert and industry interviews
FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts
FMI conducts interviews with industry experts, industry players, distributors and retailers
Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data
Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry
FMI delivers industry insights and information in the required format (PDF)

• Identifying key opinion leaders
• Questionnaire design
• In-depth interviews
• Coverage across value chain

• Key industry experts
• Channel study
• Developments
• Market dynamics
• Products
• Conclusions

SOLUTION

• Market participants
• Key strengths
• Product portfolio
• Mapping as per value chain
• Key focus segments

Primary Research
Secondary Research
Paid Publications

• Linkedin
• Zoominfo
• Salesforce
• Avention

• Factiva
• GBI
• Genios
• Meltwater

• Company websites
• Company annual reports
• White papers
• Financial reports

includes sources of databases
4
Organoids Market Analysis

• Organoids Market to Partake Significant
  Development During 2019-2029
• Traditional methods of drug discovery are
  inadequate and less relevant to the pace of the
  growing life science research and development.
  Organoids are, therefore, expected to generate a
  major revenue share in the market for drug
  discovery applications in the near future.
  Increasing failure rate in human preclinical
  trails is luring academicians and researchers to
  explore more possible organoid models for
  toxicology research and potential regenerative
  mediation research, thereby propelling the demand
  for organoids. Use of animals for research and
  testing has led to the creation of numerous
  initiatives and campaigns regarding the debatable
  issue. According to Humane Society International,
  more than 115 million animals are used for
  research in laboratories worldwide every year.
  Organoids are anticipated to substitute animals
  for testing in laboratories. Organoids are
  proving to be an appropriate alternate for animal
  testing models. The organoids market is growing
  with increasing support and initiatives to limit
  the use of animals for testing through regulatory
  guidelines. Thus, the rising focus on
  substituting animal model for research, along
  with development of commercially available
  organoids, is likely to boost the growth of the
  global organoids market.
• According to the latest report published by FMI,
  the global organoids market is expected to reach
  US 134 Mn by the forecast year 2029. The
  report further projects that the organoids market
  will grow at a CAGR of 15 during the forecast
  period 2019-2029.
• Organoids and 3D cell cultures are growing
  rapidly in popularity, replacing 2D cell culture
  in traditional methods of research in human
  developmental biology. With an alarming rise in
  the prevalence of cancer, the need for novel
  drugs has grown significantly, and this is
  expanding the scope of applications for organoids
  in oncology research. In the past few years, a
  mounting number of pharma companies have been
  focusing on introducing personalised oncology
  drugs, and leading stakeholders are joining the
  bandwagon by adopting strategies of creating
  cancer organoids for individual patients, in
  order to leverage the new avenues of growth in
  oncology research.

5
Organoids Market Analysis

• Organoids Market Dynamics
• Over the last few years, organoids have gained
  significant popularity among the research groups
  working on advanced 3D cell culture. The primary
  driver for the organoids market is considered to
  be the attainment of greater degree of
  resemblance to the cell specific structure of the
  specific organ, in vivo environmental conditions.
  Organoids are used for cell toxicity screening,
  cell-based assays, and organ specific cell
  functions. Cell cultures in 2D environment limit
  or restrict their ability to depict traits
  exhibited by in vivo systems, because of the
  morphological and locomotion limitations imposed
  by the 2D atmosphere. The ability of organoids to
  meticulously mimic the specific cells of the
  organs from which they are derived, leads to
  accurate models of tissues. This factor is
  considered to be a strong driver for the
  organoids market growth. Presently, advancements
  in 3D cell culture technology have developed a
  potential scope for development of cancer
  specific organoids with research of potential
  applications. This factor is expected to play an
  instrumental role in driving the growth of the
  organoids market.
• Europe Takes the Centre Stage in the Organoids
  Market 
• Lack of skilled professionals engaged in research
  and developmental activities is expected to
  hamper the growth of the organoids market. A
  study presented by Tufts University in Boston,
  showed that it costs around US 2.6 million to
  develop a new drug and a standard prescription
  for the commercial market approval, due to high
  failure rates in human drug testing. Organoids
  offer viable model for the human disease models
  specific to organ tissue for drug screening in
  preclinical trials.

6
Organoids Market Analysis

• Europe organoids markets are expected to witness
  significant growth, in the view of increasing
  research activities in organoids field and
  growing number of sponsor for the study in these
  regions, as well as growing trend in academic
  research to work with organoid models, to explore
  more viable applications. Additionally,
  increasing bio-banking activity in the region is
  anticipated to propel the organoid market growth.
   Furthermore, rising research and development in
  3D cell culture technology, prominent presence of
  manufacturers, and initiatives for replacing
  animal models in research studies with organoids
  are some of the factors propelling the growth of
  the organoid market. The Europe organoids market
  is estimated to create an estimated incremental
  opportunity worth approximately US 38 Mn between
  2019 and 2029.
• Organoids Market Segmental Analysis
• The global organoids market has been segmented by
  product type, application, end user, and region.
  Furthermore, the organoids market has been
  segmented by product type into Intestinal
  Organoid, Hepatic Organoid, Pancreatic Organoid,
  Colorectal Organoid, Neural Organoid and Others,
  which are used for the developing full organoid
  models for research. The application segment of
  the organoids market is segmented into
  Bio-banking, Biomedical Research and Drug
  Discovery, Regenerative Medicine, Cancer
  Research, Therapeutic Tools and Others.
  Bio-banking segment is expected to hold a large
  share during the forecast period. As per end
  user, the organoids market is segmented into
  Biopharmaceutical Companies, Contract Research
  Organizations and Academics and Research
  Institutes.

7
Organoids Market Analysis

• Organoids Market Companies
• The report tracks some of the key companies
  operating in the Organoids market, such as
  Hubrecht Organoid Technology (HUB), STEMCELL
  Technologies Inc., Cellesce Ltd., DefiniGEN, Qgel
  and OcellO B.V.
• Sourcehttp//www.globenewswire.com/news-release/2
  019/09/11/1914110/0/en/Organoids-Market-is-project
  ed-to-grow-at-a-Significant-CAGR-of-15-during-2019
  -to-2029-Future-Market-Insights.html
• More from FMIs Healthcare, Pharmaceuticals and
  Medical devices Market Intelligence
• Narcolepsy Treatment Market
• Respiratory Devices Market
• About Us
• Future Market Insights (FMI) is a leading market
  intelligence and consulting firm. We deliver
  syndicated research reports, custom research
  reports and consulting services which are
  personalized in nature. FMI delivers a complete
  packaged solution, which combines current market
  intelligence, statistical anecdotes, technology
  inputs, valuable growth insights and an aerial
  view of the competitive framework and future
  market trends.

8
Organoids Market Analysis

• Contact Us
• Mr. Abhishek Budholiya616 Corporate Way, Suite
  2-9018,Valley Cottage, NY 10989,United
  StatesT 1-347-918-3531F 1-845-579-5705T
  (UK) 44 (0) 20 7692 8790Sales sales_at_futuremar
  ketinsights.comPress Office Press_at_futuremarketin
  sights.comFuture Market Insights

9
To know more about us, please visit our website
www.futuremarketinsights.com For sales queries
or new topics email us on sales_at_futuremarketinsi
ghts.com For media queries, contact the press
office at press_at_futuremarketinsights.com For
other queries contactHari. T (Sr. Manager -
Global Business Development) Future Market
Insights 3rd Floor,207 Regent Street, London
W1B 3HH T 44 20 7692 8790 D 44 20 3287
4268 Email hari.t_at_futuremarketinsights.com
Thank You
Future Market Insights Global Consulting
Private Limited (FMI)